132 INDUCTION OF FIRST POSTPARTUM OVULATION AFTER ADMINISTRATION OF GnRH, ESTRADIOL BENZOATE, OR LH ASSOCIATED OR NOT WITH CALF REMOVAL IN NELORE COWS

2010 ◽  
Vol 22 (1) ◽  
pp. 225
Author(s):  
V. G. Pinheiro ◽  
A. C. S. Oliveira ◽  
J. R. L. M. Cury ◽  
C. M. Barros

There are reports in the literature indicating that the presence of calf, body condition score, energy balance, number of births (multiparous v. primiparous), and breed are factors that influence the duration of postpartum anoestrus in beef cows. The purpose of the present study was to evaluate, during early postpartum, the time necessary for reestablishment of pituitary LH stocks, determined by the hypothalamic-pituitary axis responsiveness to exogenous administration of GnRH and estradiol benzoate (EB). Multiparous lactating Nelore cows (n = 51) were kept in Brachiaria brizantha pasture. The animals were randomly allocated in 8 groups, according to the hormonal treatment: EB Group (1.0 mg of EB, i.m. Estrogin®, Farmavet, Sao Paulo, Brazil; n = 7), EB and calf removal (CR) group (EB/CR, calves were removed at the time of birth, n = 4), EB/SUP group (cows were supplemented with a balanced diet, based on cotton meal and ground corn, from the beginning of the experiment until ovulation), GnRH group (100 μg, licereline, i.m. Gestran Plus®, ARSA SLR, Buenos Aires, Argentina; n = 7), GnRH/CR group (n = 4), GnRH/SUP group (n = 8), LH group (12.5 mg, i.m. Lutropin® Bioniche, Ontario, Canada; n = 7), and control group (did not receive any hormone to induce ovulation or diet supplementation, n = 5).The hormones were administered weekly, from 7 days postpartum (±5 days) until the occurrence of the first ovulation, which was determined by the presence of CL during weekly ovarian ultrasonography (Aloka 900, Tokyo, Japan, 7.5 MHz probe). The data were analyzed by ANOVA. On average (±SEM) the first ovulation occurred 86.7 ± 0.5 (EB); 19.7 ± 0.6 (EB/CR); 57.8 ± 0.4 (EB/SUP); 44.7 ± 0.5 (GnRH); 25.9 ± 0.6 (GnRH/CR); 32.8 ± 0.4 (GnRB/SUP); 42.4 ± 0.5 (LH); and 59.3 ± 0.5 (control) days postpartum. There were significant differences between groups: EB v. EB/SUP (P < 0.01), EB v. EB/CR (P < 0.01), EB v. control (P < 0.04), EB v. GnRH (P = 0.01), and there was a tendency between groups: GnRH v. GnRH-SUP (P = 0.10) and LH v. control (P = 0.10). The first ovulations were detected from the second week postpartum (animals from Groups GnRH and EB/CR) until the last ultrasound examination on Day 120 postpartum (Group EB). The results indicate that from the second week postpartum there is sufficient LH in the pituitary to induce ovulation after GnRH or EB administration. However, the cows from EB group ovulated later than animals from the other groups, possibly due to the sensitivity of hypothalamus to negative feedback of estrogens, inhibiting the pre-ovulatory LH surge. Additionally, calf removal and food supplementation reduced in 2 to 4 weeks the time of the first postpartum ovulation induced by GnRH or EB. Fellowship from FAPESP. Supported from FAPESP (Sao Paulo, Brazil).

2010 ◽  
Vol 22 (1) ◽  
pp. 164
Author(s):  
F. A. Braga ◽  
F. J. D. Pardo ◽  
P. H. Miguez ◽  
A. Kehrle ◽  
J. R. V. Pimentel ◽  
...  

Artificial insemination results can be improved using fixed-timed AI (FTAI). Currently, progesterone release devices, indispensable in FTAI procedures, such as DIB® (Schering-Plough, Kenilworth, NJ, USA), are made of silicone, a nonbiodegradable biocompatible polymer. Recently, biodegradable progesterone (P4)-releasing devices made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactona (PCL) have been developed. To investigate the efficiency on pregnancy rate of FTAI programs using a new intravaginal device made of PHB-V (Progestar®, Innovare, São Paulo, Brazil), 240 Nellore (Bos indicus) cows, between 3 and 8 years of age, were randomly assigned to 2 experiments. In experiment 1, new P4 devices DIB (control group, DIB1; n = 60) were compared with PHB-V (Progestar1; n = 76); in experiment 2, previously used DIB (DIB2; n = 52) and PHB-V (Progestar2; n = 52) devices were compared. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal device according to group (Day 0). Together with P4 device withdrawal (Day 8) all animals received 300IU of eCG i.m. (Novormon®, Schering-Plough) and 150 μg i.m. of D-cloprostenol (Croniben®, Biogenesis-Bagó, Buenos Aires, Argentina). On Day 9, all cows were treated with 1 mg of estradiol benzoate and the FTAI was performed 30 h later. The data were submitted to ANOVA (PROC GLM of SAS, SAS Institute, Cary, NC, USA), separating as causes of variance the effect of treatment, postpartum period (PPP1-45 until 70 days and PPP2-71 until 90 days), body condition score (BCS4, BCS5, and BCS6 using a 1 to 9 scale), cyclicity (cycling and noncycling) and clean-up bulls (5 bulls nominated with numbers 1 to 5). Significant differences were considered to have P < 0.05. In experiment 1, interactions were not significant, there was no effect of treatment on FTAI (DIB1: 66.7% v. Progestar1: 65.8%) or breeding season pregnancy rates (BSPR; DIB1: 95.0% v. Progestar1: 94.7%) and no effect of other variables on FTAI pregnancy rates (FTAIPR) and BSPR. In experiment 2 there was no effect of treatment on FTAIPR (DIB2: 61.6% v. Progestar2: 55.8%) and BSPR (DIB2: 94.2% v. Progestar2: 88.5%). As ANOVA indicated a significant effect of clean-up bulls on BSPR, Tukey test was used to split it up. A bull of the Progestar2 group had lower performance (41.7%) causing the difference (albeit nonsignificant) on BSPR. This experiment showed that Progestar and DIB had the same efficiency on pregnancy rate and both treatments have the potential to produce FTAIPR >50% and BSPR >90%. Fapesp-Fundação de Amparo à Pesquisa do Estado de São Paulo. CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.


2010 ◽  
Vol 22 (1) ◽  
pp. 162
Author(s):  
J. Almeida ◽  
O. A. Resende ◽  
D. L. Silveira

With the goal of optimizing protocols, fixed-time artificial insemination (FTAI) was performed under field conditions in a study to evaluate conception rates in Girolando (5/8) heifers (18 to 24 months of age) treated with estradiol benzoate (BE) to induce ovulation. Forty heifers were allocated to 2 groups with 20 animals each: GI-sexed semen (2 million spermatozoa/dose) and GII-nonsexed semen (20 million spermatozoa/dose), with body condition score (BCS) of 3.0 ± 0.14 (scale of 1 to 5), middleweight of 335 ± 38 kg, so that it was made for reutilization of progesterone device. On Day 0 (morning), the animals received 2.0 mg of BE (RIC-BE®,Tecnopec, São Paulo, Brazil), 0.075 mg of D-cloprostenol (Prolise®, ARSA S.R.L., Buenos Aires, Argentina), and an intravaginal device of 1 g of progesterone (Primer®, Tecnopec). On Day 8 (morning) the device was removed and 0.075 mg of D-cloprostenol was managed in the GI animals, then these animals received 1.0 mg of BE 24 h after device removal. The insemination was in the late afternoon of Day 10 with a 6-hour delay (4 to 6 pm). The GII animals received Primer previously used for 8 days (being used in the GI animals under the same protocol). After pregnancy diagnosis at 60 days, a third group was created (GIII) using the not-pregnant animals of GI and GII. In GIII, Primer from third use [disinfected in solution Kilol®-L 1:250 (Quinabra, São Paulo, Brazil) and rinsed with water, dried, and packed in plastic sacks and kept for 60 days] was used following the GI protocol with sexed semen. There were no significant differences (P > 0.05) in the conception rates of 40, 58, and 65% among groups GI (8/20), GII (11/20), and GIII (13/20). These results indicate very good conception rates for heifers, contrary to recommendations of commercial companies of sexed semen that alert for the conception rate for mated animals to be lower when using FTAI and mating protocols in mass, compared with that of AI after estrus observation.


2010 ◽  
Vol 22 (1) ◽  
pp. 247
Author(s):  
J. R. V. Pimentel ◽  
P. H. P. Miguez ◽  
A. Kehrle ◽  
E. H. Madureira ◽  
F. A. Braga ◽  
...  

Progestagen-releasing devices are commonly used for fixed-time artificial insemination and fixed-time embryo transfer (FTET). The aim of this study was to evaluate the efficacy of a new progesterone-releasing intravaginal device made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactone (PCL; Progestar®, Innovare, São Paulo, Brazil) to synchronize crossbredcows and heifers for FTET by determining ovulation, conception, and pregnancy rates. A total of 205 recipients ranging in age from 2 to 8 years (heifers, n = 77; non-suckled cows, n = 69; suckled cows, n = 59) were used on 3 different farms during February, March, and April 2008. The experimental design was a generalized block design (cyclicity, body condition score, postpartum interval, and animal category, i.e. heifers, suckled, or non-suckled cows), with 2 different synchronization treatments for FTET (Progestar® v. Crestar®). Cows were assigned to either Crestar® (norgestomet ear implants; Intervet Schering-Plough, Kenilworth, NJ, USA; n = 103) or Progestar® (PHB-V; n = 102) treatments. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal or auricular device according to their group (Day 0). Together with P4 device withdrawal (Day 8), all animals received 400 IU of eCG i.m. (Novormon®, Schering-Plough) and 500 μg i.m. of PGF2α, (Sincrocio®, Ouro Fino, Brasil). On Day 9, all cows were treated with 1 mg of estradiol benzoate (Innovare) and the innovulation was performed on Day 17. Embryos were maintained at 37°C during the innovulation period. The percentage of usable recipients (AR) based on the presence of a functional CL on the day of embryo transfer, conception rate (numbers of pregnant recipients of the total number transferred; CR), and pregnancy rate (numbers of pregnant recipients of the total number synchronized; PR) were determined by ultrasonography 23 days after embryo transfer. Data were submitted to ANOVA (PROC GLM, SAS Institute Inc., Cary, NC, USA) and significant differences were considered to have a P-value of <0.05. None of the interactions were significant and there was no effect of treatment on AR (72.8% v. 83.3%), CR (47.9% v. 42.7%), and PR (34.7% v. 35.0%) for Progestar® v. Crestar® groups, respectively. This experiment showed that Progestar® was as efficacious as Crestar® to synchronize crossbred cows and heifers for FTET. FAPESP-Fundação de Amparo à Pesquisa do Estado de São Paulo and CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.


2010 ◽  
Vol 22 (1) ◽  
pp. 174
Author(s):  
V. A. Nascimento ◽  
G. S. Moura ◽  
M. Dias ◽  
F. A. Oliveira ◽  
A. R. Dias ◽  
...  

The objective of this study was to evaluate the administration of the follicle-stimulating hormone (FSH-p) or equine chorionic gonadotropin (eCG) in protocols of ovulation synchronization. One hundred forty-nine crossbred Holstein-Gyr cows were used in 2 properties in Minas Gerais and 3 treatments: TControl (n = 49 cows), Day 0: insert of a progesterone device (Primer®, Tecnopec, São Paulo, Brazil) + 2 mg of estradiol benzoate (RIC-BE®); Day 8: removal of Primer + 112 mg of D-cloprostenol (Prolise®, ARSA SRL, Buenos Aires, Argentina) + 1 mg of estradiol benzoate and fixed-time artificial insemination (FTAI) accomplished 44 h after the removal of Primer; TFSH (n = 50 cows), similar to TControl, but on Day 8, 15 mg of FSH-p (Folltropin®, Bioniche Animal Health) was administered; TeCG (n = 50 cows), similar to TControl, with administration on Day 8 of 300 IU of eCG (Novormon®, Syntex SA, Buenos Aires, Argentina). Cows that returned to estrus 14 to 28 days after the FTAI were inseminated once again. For all statistical analysis, we used the program SAS 9.0 (2002; SAS Institute Inc., Cary, NC, USA) at 5% probability. Quantitative variables (live weight, days postpartum, follicular average per cow) were analyzed by variance, and body condition score by Friedman test. The pregnancy rates were submitted to logistic analysis considering the effect of local experimental factors and were analyzed by Spearman correlation among the variables studied and the pregnancy rate. There was no difference (P > 0.05) between treatment for pregnancy rate in FTAI protocols (TControl = 40.82%; TFSH = 38.00%; TeCG = 26.00%), in the first insemination after FTAI (TControl = 56.25%; TFSH = 70.59%; TeCG = 68.42%), and in FTAI plus first insemination after FTAI (TControl = 59.18%; TFSH =62.00%; TeCG = 52.00%), as well as for the estrus repetition (TControl = 55.17%; TFSH = 54.84%; TeCG = 51.35%) and the correlation (P > 0.05) among the pregnancy rate and postpartum period, milk production, body weight and body condition. No effect was observed on the pregnancy rate by the addition of the hormones FSH and eCG in the protocol of ovulation synchronization in crossbred Holstein-Gyr cows; however, reinsemination in the period from 14 to 28 days after FTAI increased the pregnancy rate. CNPq; FAPEMIG; TECNOPEC/São Paulo, Brazil.


2010 ◽  
Vol 22 (1) ◽  
pp. 260 ◽  
Author(s):  
H. Ayres ◽  
R. M. Ferreira ◽  
M. C. Wiltbank ◽  
P. S. Baruselli

Programs that allow timed AI (TAI) have been used to improve reproductive efficiency in dairy herds; however, in many cases pregnancies per AI (P/AI) during these programs remain suboptimal. In the present experiment, it was hypothesized that treatment with FSH or eCG at the time of the PGF2 treatment of the TAI protocol would increase fertility in dairy cattle. This experiment was performed in June 2008 (winter) and January 2009 (summer) on 2 commercial dairy farms located in southeast Brazil. On a random day of the estrous cycle (Day 0), 694 cows at 196 ± 138 days in milk (DIM) received 2 mg of estradiol benzoate (RICB®, Tecnopec, São Paulo, Brazil) i.m. and a releasing intravaginal device (P4; Primer®, Tecnopec), which was removed on Day 8 when 150 μg of PGF (Prolise®, ARSA, Buenos Aires, Argentina) i.m. were administered. At this time, the cows were stratified by days in milk (DIM), parity, number of insemination, milk production, presence of a CL on Day 0, and body condition score (BCS) and were randomly assigned to 1 of 3 treatments: control (n = 232), consisting of no additional treatment; eCG (n = 232), consisting of 400 IU of eCG (Folligon®, Intervet, São Paulo, Brazil); and FSH (n = 230), consisting of 20 mg of FSH (Folltropin®, Bioniche, Belleville, Ontario, Canada). All cows received GnRH (100 μg of gonadorelin; Fertagyl®, Intervet) and were TAI 56 h after the removal of the device. Pregnancy diagnosis was performed 30 and 60 days after TAI. Also, a subset of animals (n = 89) was submitted to ultrasonographic exams to evaluate the diameter of the ovulatory follicles (ØOF), time to ovulation after P4 removal (TOV), and ovulation rate (OR). Statistical analyses were performed with logistic regression by PROC GLIMMIX of SAS (SAS Institute, Cary, NC, USA). There were no interactions of treatment with DIM, parity, number of insemination, BCS, locomotion score, sire, batch, inseminator, farm, or month; therefore, these variables were removed from the statistical model. The overall P/AI was different between treatments at 30 days after TAI [control = 28.0% (65/232), eCG = 29.7% (69/232), and FSH = 18.7% (43/230); P = 0.01], but not at 60 days [control = 21.6% (50/232), eCG = 24.1% (56/232), and FSH = 16.1% (37/230); P = 0.08]. Pregnancy loss was also similar among treatments [control = 23.1% (15/65), eCG = 18.8% (13/69), and FSH = 14.0% (6/43); P = 0.08]. In addition, the treatments (control, eCG, and FSH, respectively) were not different among ØOF (13.78 ± 0.52; 14.50 ± 0.59; and 15.35 ± 0.69 mm; P = 0.15); TOV (82.50 ± 2.14; 78.48 ± 2.35; and 78.96 ± 2.39 h after P4 withdrawal; P = 0.30); or OR [82.76% (24/29); 83.33% (25/30); and 83.33% (25/30); P = 0.44]. Thus, these data do not indicate a major fertility-enhancing effect of a single eCG or FSH treatment during protocol for TAI in high-producing dairy cows, contrary to the hypothesis of the present study. Tecnopec, Fazenda Campestre, Agrindus S/A, Echoa e Nutricell Nutrientes Celulares.


2004 ◽  
Vol 16 (2) ◽  
pp. 127 ◽  
Author(s):  
G.A Bo ◽  
L. Cutaia ◽  
P. Chesta ◽  
D. Moreno

Treatments with progesterone (P4) releasing devices and estradiol benzoate (EB) have been extensively used in fixed-time AI (FTAI) programs in beef cattle. However, pregnancy rates in postpartum cows kept on pasture often have been lower than expected because of poor body condition score (BCS) and a high incidence of anestrous. A recent study (Cutaia L et al., 2003 Theriogenology 59, 216) suggested that the addition of eCG to a P4/EB FTAI program may improve pregnancy rates in cows with fair to poor BCS, but results were not conclusive. Therefore, this experiment was designed to further investigate the effect of eCG treatment on pregnancy rates in postpartum beef cows in those conditions. The experiment was performed at 2 locations with lactating Angus cows (n=93), 60 to 90d postpartum with a BCS 1.9 (1 to 5 scale; Location 1), and crossbred Zebu cows (n=290), 60 to 90d postpartum with a BCS 2.0 (Location 2). In each Location, cows were randomly allocated to 1 of the following treatment groups: Control, eCG Day6, or eCG Day8. All cows received a P4 intravaginal device (DIB, Syntex, Argentina) and 2mg EB i.m. (Syntex) on Day0, 500mg cloprostenol (Estroplan, Syntex) at the time of DIB removal (Day8), 1mg EB i.m. on Day9 and FTAI 52 to 56h after DIB removal. Cows in the Control group received no further treatment, whereas cows in the eCG-treated groups received 400 IU eCG (Novormon 5000, Syntex) on Day6 or Day8. Cows were examined on Day0 by rectal palpation (Location 1) or by ultrasonography (US; Location 2) and were classified as those with a CL or without a CL, with either large (&gt;8mm) or small (&lt;8mm)small follicles. Pregnancy was determined by US 45d after FTAI. Data were analyzed by logistic regression and the effects of location, treatment, ovarian status, AI technician and semen were considered in the model. There was no effect of location (P=0.3), AI technician (P=0.2) or semen (P=0.8) on pregnancy rates. However, there was an effect of treatment (P=0.02), attributed to higher pregnancy rates in the eCG Groups than in the Control Group (Table). Furthermore, cows with a CL or without a CL but with large follicles on Day 0 had higher pregnancy rates than those with small follicles (P=0.04). It was concluded that the use of eCG in a P4/EB FTAI program improved pregnancy rates in postpartum beef cows that were in fair topoor BCS.


2012 ◽  
Vol 24 (1) ◽  
pp. 144
Author(s):  
V. G. Pinheiro ◽  
J. R. L. M. Cury ◽  
R. A. Satrapa ◽  
M. F. Pegorer ◽  
C. M. Barros

The presence of calf, body condition score, energy balance, number of births (multiparous vs primiparous) and breed are factors that influence the duration of postpartum anoestrus in beef cows. The objective of the present study was to evaluate, during early postpartum, the time of re-establishment of pituitary LH stocks, measured by the hypothalamic-pituitary-axis responsiveness to exogenous administration of gonadotropin-releasing hormone (GnRH) or oestradiol benzoate (EB). Multiparous lactating Nellore cows (Bos indicus, n = 65) were randomly allocated into 6 groups, according to the hormonal treatment: EB group (1.0 mg of EB, IM, n = 7), GnRH group (50 μg of lecireline, IM, n = 16). The EB-supplemented (SUP; n = 9) and GnRH-SUP (n = 16) groups received the same treatments specified above and were SUP with a balanced diet, based on cotton meal and ground corn (3.5 kg cow–1 per day). Additionally, animals from EB-calf removed (CR; n = 4) and GnRH-CR (n = 13) groups received the same treatments of EB and GnRH group, respectively and had their CR shortly after parturition. The hormones were administered weekly, from 7 days postpartum (±5 days) until the occurrence of the first ovulation, which was determined by the presence of corpus luteum during ovarian ultrasonography performed weekly. Blood samples were collected just before and 2 h (GnRH groups) or 18 h (EB groups) after hormone administration, in order to determine LH concentration by radioimmunoassay. Data were analysed by ANOVA. Mean values in days (± standard error of the means) for the first postpartum LH surge were EB (73.0 ± 5.2); EB-CR (16.7 ± 5.8); EB-SUP (41.7 ± 6.7); GnRH (32.3 ± 3.0); GnRH-CR (11.0 ± 3.5); GnRH-SUP (15.6 ± 2.8). There were significant differences (P < 0.05) between groups EB vs EB-CR; EB vs EB-SUP; BE vs GnRH; GnRH vs GnRH-CR; GnRH vs GnRH-SUP and a tendency between EB-SUP vs EB-CR (P < 0.10). Results indicate that from the second week postpartum, there is sufficient LH in the pituitary to induce ovulation after GnRH or EB administration. However, the cows from the EB group ovulated later than animals from the other groups, possibly due to the sensitivity of the hypothalamus to negative feedback of estrogens, inhibiting the pre-ovulatory LH surge. Additionally, CR and food SUP reduced in 2 to 4 weeks the time of the first postpartum LH surge induced by GnRH or EB in Nellore cows. A fellowship was received from FAPESP. Support was received from FAPESP.


2014 ◽  
Vol 26 (1) ◽  
pp. 120
Author(s):  
G. Pugliesi ◽  
E. Lopes ◽  
A. M. G. Diaza ◽  
M. R. França ◽  
R. S. Ramos ◽  
...  

Recent evidence indicates that progesterone (P4) secretion from corpus luteum (CL) is affected by preovulatory follicle (POF) size and that increased circulating P4 during early diestrus has a positive effect on embryo development and pregnancy rates in cattle. Despite the embryotrophic effects, early administration of P4 may impair CL growth and anticipates luteolysis. Owing to develop favourable peri-ovulatory endocrine milieus to pregnancy success, we evaluated in beef cows (1) the effect of CL presence during dominant follicle growth on follicular vascularization, size and ovulation rate and (2) the effects of POF size and supplementation of long-acting P4 post-AI on CL development and regression. Sixty-six Nelore cows received an intravaginal P4 device and an injection of oestradiol benzoate on Day 10 (5–10 days post-oestrus), and were split to receive sodium cloprostenol [prostaglandin F2α (PGF2); large follicle (LF); n = 31) or not [small follicle (SF); n = 35]. Devices were removed and PGF2 was injected on Day 1.75. Ovulation was induced with a gonadotropin-releasing hormone (GnRH; buserelin acetate) on Day 0. Cows were inseminated twice on Days 0.5 and 1. Cows that ovulated were assigned to receive placebo (LF/control group, n = 14; and SF/control group, n = 9) or 150 mg of long-acting P4 on D4.5 (LF/P4 group, n = 13; and SF/P4 group, n = 12). Colour-Doppler ultrasound scanning was done on Days 10, 6, 2, 0.5, 1, 1.5, 4.5, 7.5, and 15.5. Structural luteolysis was detected by 25% decrease in CL area and 50% in luteal blood flow of subsequent scanning. Data were analysed for the main effects of POF size and supplementation and their interaction using the PROC MIXED procedure of SAS (SAS Institue Inc., Cary, NC, USA). Follicle diameter (mm) on Day 2 (11.4 ± 0.4 v. 8.4 ± 0.3) and POF (14.1 ± 0.3 v. 12.5 ± 0.3) were greater (P < 0.05) in LF group. Percentage of luteal blood flow in follicle wall was greater (P < 0.05) on Day 0.5 (33.9 ± 3.4 v. 22.8 ± 3.6) and 1 (48.9 ± 4.8 v. 28.3 ± 4.3) in the LF group. Ovulation rate was lower (P < 0.05) in the SF group (60%, 21/35) than in the LF group (90%, 28/31), suggesting that a functional CL during dominant follicle growth is less favourable to pregnancy success due to 30% reduction in fertilizing potential of non-ovulated follicles. For luteal area (cm2), an effect (P < 0.05) of POF size was detected on Day 4.5 (1.7 ± 0.1 v. 1.3 ± 0.1), 7.5 (2.8 ± 0.2 v. 2.2 ± 0.1), and 15.5 (2.5 ± 0.1 v. 2.2 ± 0.2) in the LF and SF groups, respectively. Luteal blood flow was greater (P < 0.05) in the LF groups (40.4 ± 1.7 and 47.6 ± 3.4) than in the SF groups (35.7 ± 1.5 and 37.9 ± 4.1) on Day 4.5 and 15.5, respectively. This indicates that larger and more vascularized POF may be associated with greater CL vascularization in addition to greater CL size. The frequency of cows with early luteolysis did not differ (P > 0.1) between P4-treated (5/25) and placebo-treated (1/23) cows. We suggest that the P4 supplementation did not severely induce early luteolysis in inseminated cows and that the P4-embryotrophic effects may down-regulate the mechanisms involved in the earlier luteolytic process caused by greater exposure of uterus to P4. Support for this study was provided by the São Paulo Research Foundation (FAPESP, Sao Paulo, Brazil) and Ourofino (Cravinhos, SP, Brazil).


2009 ◽  
Vol 21 (1) ◽  
pp. 146
Author(s):  
V. G. Pinheiro ◽  
R. A. Satrapa ◽  
R. A. L. Simões ◽  
F. S. Rosa ◽  
C. M. Barros

There are reports in the literature indicating that the presence of calf, body condition score, number of births (multiparous v. primiparous), and breed are factors that influence the duration of postpartum anestrus in beef cows. The purpose of the present study was to evaluate, during early postpartum, the time of the reestablishment of LH stocks, measured by the hypothalamic-pituitary axis responsiveness to exogenous administration of gonadotropin-releasing hormone (GnRH) or estradiol benzoate (EB). Primiparous lactating Nellore cows (n = 38, body condition score 2.5 to 3.5, on a 0 to 5 scale) were kept in a Brachiaria brizantha pasture. The animals were randomly allocated into 2 groups, according to hormone treatment: EB group (1 mg EB, i.m., Estrogin®, Farmavet, Sao Paulo, Brazil; n = 20) and GnRH group (100 μg, licerelina, i.m, Gestran Plus®, ARSA S.L.R., Buenos Aires, Argentina; n = 18). In each group, half of the animals were supplemented with a balanced diet based on cotton meal and ground corn. The drugs were administered from 7 days postpartum (±4 days), at intervals of 7 days, until the occurrence of the first ovulation that was observed by weekly ultrasonography (US, Aloka 900, Tokyo, Japan; 7.5-MHz transrectal probe). The data were analyzed by ANOVA (Proc GLM, SAS Institute, Cary, NC). Within the GnRH and EB groups, the first ovulation occurred 15 and 33 days postpartum, respectively, whereas the group averages (± SD) occurred earlier in cows treated with GnRH compared with those treated with EB (43.0 ± 3.8. v. 75.1 ± 8.7 days postpartum, respectively; P < 0.01). In the EB group, 4 animals did not ovulate until Day 140 postpartum. There was no interaction of treatment (GnRH, EB) × nutrition (supplemented, nonsupplemented). When data from the EB and GnRH groups were combined, there was a significant difference between supplemented and nonsupplemented animals (44.4 ± 6.2 v. 68.9 ± 7.3 days, respectively; P < 0.02). The results indicate that GnRH induces ovulation from Day 15 postpartum, suggesting the presence of sufficient LH in the pituitary to induce the first ovulation at this time. However, EB administration did not induce ovulation in this period, possibly because of the sensitivity of the hypothalamus to negative feedback of estrogens, inhibiting the preovulatory LH surge. These results also indicate that nutritional supplementation anticipates the first postpartum ovulation induced by GnRH or EB. Support by FAPESP(Sao Paulo, Brazil); fellowship from FAPESPA; fellowship from CAPESB.


2010 ◽  
Vol 22 (1) ◽  
pp. 161
Author(s):  
J. R. S. Torres-Júnior ◽  
J. A. T. Souza ◽  
M. I. S. Silva ◽  
J. S. Costa ◽  
G. S. Lima ◽  
...  

The duration of spermatic viability in the female reproductive system in cattle is 18 to 24 hours. Therefore, the time required for sperm capacitation in different bulls demonstrated to be highly variable and may affect the adequate amount of capacitated sperm within an optimal window of time for fertilization. The aim of this study was to evaluate the conception rate in Nelore cows inseminated with semen from a single bull compared with semen from a pool of 3 bulls (Fertility Plus®, ABS Pecplan, Minas Gerais, Brazil). On a random day of the estrous cycle (Day 0), 400 Nelore multiparous cows received a progesterone intravaginal device (1 g of P4, DIB®, Intervet/Schering-Plough, Cotia, Brazil) plus 2mg of estradiol benzoate (i.m. Estrogin®, Farmavet, São Paulo, Brazil). At the time of P4 device withdrawal (Day 8), 150 (ig of d-cloprostenol (i.m. Preloban®, Intervet/Schering-Plough), 1 mg of estradiol cypionate (i.m. ECP®, Pfizer, Brazil), and 300IU of eCG (i.m. Folligon®, Intervet/Schering-Plough) were administered. At 48 to 52 h after implant removal, all cows were fixed-time inseminated (FTAI). Then, cows were homogeneously distributed based on the semen used for FTAI in 4 groups: CONV1 (conventional dose of semen from bull 1), CONV2 (conventional dose of semen from bull 2), CONV3 (conventional dose of semen from bull 3), FERT (pool of semen from bulls 1, 2 and 3 homogeneously mixed in a single dose). Both conventional and Fertility Plus batches of semen contained a total dose of 30 × 106 spermatozoa. For pregnancy diagnosis, an ultrasonographic (CHISON 500VET, USP Brasil Eletromedicina, São Paulo, Brazil) examination was performed 30 days after the FTAI. Data were analyzed using the GENMOD procedure of SAS (SAS Institute, Cary, NC, USA). There was no interaction between treatment and body condition score [using a 1 (very thin) to 5 (very fat) point scale] or AI technician. The conception rates for CONV1, CONV2, CONV3, and FERT were, respectively, 40/101 (39.6%)b, 50/99 (50.5%)ab, 46/99 (46.5%)ab, 54/101 (53.5%)a; P < 0.05. In addition, the mean of conventional v. Fertility Plus treatments presented conception rates of 136/299 (45.5%) v. 54/101 (53.5%), respectively (P = 0.14). No significant statistical differences were observed between treatments. However, this trial showed that the utilization of the new Fertility Plus technology increased the overall conception rate by 8.0%. This probably implicates a complementary effect among semen samples and provides a greater time of sperm viability in oviduct. Also it provides evidence of the individual variation in capacitation time of bulls used for composition of the pool. Pooled semen of multiple sires may improve the reproductive performance at AI in cattle and increase the potential of the beef industry to produce pregnancies and born calves.


Sign in / Sign up

Export Citation Format

Share Document